In humans, heterozygous PDX1 mutations are frequently associated with maturity-onset diabetes of the young type 4 (MODY4) [42], whereas homozygous mutations typically result in neonatal diabetes mellitus (NDM) [43]. Here, PDX1 is linked to MODY.